Viloxazine for ADHD
The Carlat Psychiatry Report, Volume 19, Number 11&12, November 2021
Thomas Jordan, MD.
Dr. Jordan has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
This repurposed antidepressant was recently approved in ADHD, but how does it compare with other treatments?